| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.36 | 0.02 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.02 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.02 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.4 | 0.03 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |